A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies
Crossref DOI link: https://doi.org/10.1186/s12951-016-0209-6
Published Online: 2016-07-11
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bisht, Savita
Schlesinger, Martin
Rupp, Alexander
Schubert, Rolf
Nolting, Jens
Wenzel, Jörg
Holdenrieder, Stefan
Brossart, Peter
Bendas, Gerd
Feldmann, Georg